US$ 21.20
hypoglycemia and glp 1 Exaggerated GLP-1 secretion underlies hyperinsulinemic #hypoglycemia in some individuals post #bariatric surgery contributes to improved beta cell function. Yet #diabetes remission is very rapid postop, never been shown to correlate with Relative effects of glucagon-like peptide-1
Description
Diabetes Care 28(5):10921100 DeFronzo RA, Okerson T, Viswanathan P, Guan X, Holcombe JH, MacConell L (2008) Effects of exenatide versus sitagliptin on postprandial glucose, insulin and glucagon secretion, gastric emptying, and caloric intake: a randomized, cross-over study

Molecular adaptations of the blood-brain barrier promote stress resilience vs depression
Glucagon-like peptide 1 (GLP-1) agonists including brand names like Ozempic and Wegovy were created to help people with type 2 diabetes make more insulin and lower their blood sugar

"For years, we've said 'it's choice, not chance.' That was wrong," Sistani told Axios in an interview

Presented at: The 23rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease
